(Z)-4-((tert-butyldimethylsilyl)oxy)but-2-en-1-ol, 95%, 2g

5-Methyl-3-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1,2,4-oxadiazole, 97%, 250mg

4-(4,4-Difluoro-1-piperidyl)aniline, 98%, 250mg

(S)-4-Phenylthiazolidine-2-thione>98.0%(GC)1g

7-[5-[[4-[4-[(Dimethylamino)sulfonyl]-1-piperazinyl]phenoxy]methyl]-1,3-dimethyl-1H-pyrazol-4-yl]-1-[2-(4-morpholinyl)ethyl]-3-[3-(1-naphthalenyloxy)propyl]-1H-indole-2-carboxylic acid, 98%, 50mg

3-(3-Bromobenzyl)-1-(tert-butoxycarbonyl)piperidine-3-carboxylic acid, 98%, 250mg

(E)-4-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)vinyl)aniline, 98%, 1g

3-(3-bromophenyl)-3'-chloro-5'-fluoropropiophenone, 97.0%, 1g

4-Bromo-4',4''-dimethoxytriphenylamine>98.0%(HPLC)(N)5g

Methyl (S)-2-((tert-butoxycarbonyl)amino)-3-(4-(prop-2-yn-1-yloxy)phenyl)propanoate, 98%, 5g

(1R*,4R*)-N1,N1-Dimethylcyclohexane-1,4-diamine dihydrochloride, 10g

(4-((TERT-BUTOXYCARBONYL)AMINO)-2-FLUOROPHENYL)BORONIC ACID, 95.0%, 5g

trans,trans-4-Pentyl-4'-vinylbicyclohexyl>98.0%(GC)5g